INTRODUCTION

Stevens-Johnson syndrome (SJS) is a form Toxic Epidermal
Necrolysis (TEN), a life-threatening skin condition, in which cell death causes the epidermis to separate from the dermis. 1 The syndrome is thought to be a hypersensitivity complex that affects the skin and the mucous membranes. 2 The immune reaction can be triggered by drugs or infections. 3 Genetic factors are associated with a predisposition to SJS. 4 The cause of drug induced SJS is unknown in one-quarter to one-half of cases. 4 Although use of cephalosporins (mainly cephalexin) has been associated with development of SJS, cefotaxime, a third-generation cephalosporin, has been suspected of being associated with SJS in 2 reports only. 5, 6 We describe the case of a 26-year-old woman who developed SJS temporally related to cefotaxime administration.
CASE REPORT
A 25 year old lady had consulted a dentist for a tooth-ache. She was therefore prescribed antibiotics and painkillers, namely cefotaxime 1 gm thrice daily and FDC of paracetamol (500 mg) and tramadol (50 mg) thrice daily. She had never received cefotaxime before. There was no history of any autoimmune disease and patient had denied the use of over-the-counter medications. There was no history of drug allergy or any recent immunization.
Three days later, she was febrile; and had started to develop a systemic maculopapular rash along with erosive lesions Cefotaxime was stopped, and substituted with amoxicillinclavulinic acid. The patient received a short course corticosteroid treatment (methylprednisolone 80 mg/day for 7 days). 10 days later, there was marked improvement in her condition. Concurrent medications were gradually started during hospitalization without any problem. She was finally discharged on day 14 th and remained in good health at 28 th day follow-up.
Cefotaxime-induced Stevens-Johnson syndrome
DISCUSSION
Steven-Johnson syndrome (SJS) is an immune-complex mediated hypersensitivity reaction involving skin and mucus membrane. 7 It is an acute life-threatening condition, often caused by certain infections or drugs. The severity spectrum is based on the degree of body surface area detachment (BSA): 1. SJS: A minor form of Toxic Epidermal Necrolysis (TEN), with < 10% BSA detachment 2. Overlapping SJS/TEN: BSA detachment 10-30% 3. TEN: BSA detachment > 30%
Patients of SJS typically present with prodormal symptoms of productive cough, headache, malaise and arthralgia. Rash is typically symmetrical, involving mostly face, neck and chest. The cutaneous lesions are burning in nature, developing into papules, vesicles, bullae, urticarial plaques or confluent erythema. 8 The lesion's core may be vesicular, purpuric or necrotic, surrounded by macular erythema, but later become bullous and rupture with denudation of skin and increased susceptibility to infection to follow. Urticarial lesions are typically not pruritic. The rashes may involve palms, soles, limbs and trunk. Mucus membranes may be involved with varying degree of erythema, edema, sloughing, ulceration or even necrosis. Involvement of mucus membrane and absence of pathognomic target lesions are keys to differentiate SJS from Erythema Multiforme. 9 Ocular signs like blepharitis, periocular edema, trichiasis, conjuctival shrinkage, foreshortening of fornices, symblepharon. Slit-lamp examination of cornea and conjunctiva may reveal superficial punctuate keratitis, stromal ulcers, stromal opacity, neovascularisation or even perforation. 10 Skin biopsy may help differentiate the condition from other intraepidermal bullous diseases not related to drug 12 Management is symptomatic, with special attention to airway and hemodynamic stability, wound care and pain alleviation measures. 13 Recognition and cessation of responsible drug or treatment of precipitating infection is the mainstay. Topical anesthetics, mouthwashes are prescribed for painful oral lesions. Denuded skin areas are managed with compresses of saline. Tetanus toxoid prophylaxis and antibiotic coverage is usually recommended. Extensive debridement of non-viable skin followed by dressing is recommended. 14 Although our patient was given corticosteroids, the value of systemic steroids in this syndrome is controversial. 15 Ocular complication can be mitigated with aggressive usage of lubrications. Long standing cases often require topical steroids to counter ensuing inflammation and cicatricial changes along with removal of keratinized plaques or superficial keratectomy of keratinized ocular surfaces. Newer modalities under research include limb stem cells transplantation, amniotic grafting etc.
More than 100 drugs have been implicated as causes of SJS, with sulfonamides, antiepileptic agents, oxicam derivatives, allopurinol, chlormezanone, and steroids being the most commonly listed ones. 16 Cephalosporin-induced allergic skin reactions are usually mild. In our case, the patient was on many drugs, but temporal association with the administration of oral cefotaxime and pathogenesis of SJS was concluded as disease worsening was prevented with the drug withdrawal.
CONCLUSION
The diagnosis of a possible cefotaxime-induced SJS remains presumptive or probable, but may be considered 'possible' in our case. Since the condition may have an immunological basis, additional cases and supportive data may be needed to establish a definite causal relationship.
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